Vendor, Boston, MA
Amplitude Therapeutics, Inc.
UEI LKKRWNJ3WQN7, CAGE 9VMN7
1 award and $732,813 obligated between August 20, 2024 and August 20, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $732,813 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $732,813 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50124C00036Definitive Contract, August 20, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Amplitude Therapeutics-A Split-Formulated Trans-Amplifying Rna Encoded Anti-Neuraminidase Monoclonal AntibodyNAICS 541714, PSC AN13 | $732,813 |
- Places of performance
- Massachusetts
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards